{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:39:30Z","timestamp":1785937170259,"version":"3.56.0"},"reference-count":83,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR20\/00012"],"award-info":[{"award-number":["JR20\/00012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01061"],"award-info":[{"award-number":["PI18\/01061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive fungal disease (IFD) is a common cause of morbidity and mortality in patients with hematologic malignancies, especially among those undergoing allogeneic hematopoietic stem cell transplantation (HSCT). The epidemiology of IFD in HSCT patients has been evolving over the last decades, mainly in relation to changes in HSCT therapies such as antifungal prophylaxis. A progressive decrease in Candida albicans infection has been documented, alongside a progressive increase in infections caused by non-albicans\u00a0Candida species, filamentous fungi, and\/or multidrug-resistant fungi. Currently, the most frequent IFD is invasive aspergillosis. In some parts of the world, especially in north Central Europe, a high percentage of Aspergillus fumigatus isolates are azole-resistant. New diagnostic techniques have documented the existence of cryptic Aspergillus species with specific characteristics. An increase in mucormycosis and fusariosis diagnoses, as well as diagnoses of other rare fungi, have also been described. IFD epidemiology is likely to continue changing further due to both an increased use of mold-active antifungals and a lengthened survival of patients with HSCT that may result in hosts with weaker immune systems. Improvements in microbiology laboratories and the widespread use of molecular diagnostic tools will facilitate more precise descriptions of current IFD epidemiology. Additionally, rising resistance to antifungal drugs poses a major threat. In this scenario, knowledge of current epidemiology and accurate IFD diagnoses are mandatory in order to establish correct prophylaxis guidelines and appropriate early treatments.<\/jats:p>","DOI":"10.3390\/jof7100848","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:23:25Z","timestamp":1633901005000},"page":"848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Changing Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2490-0217","authenticated-orcid":false,"given":"Pedro","family":"Puerta-Alcalde","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Hospital Clinic of Barcelona, C\/Villarroel 170, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0683","authenticated-orcid":false,"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Clinic of Barcelona, C\/Villarroel 170, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2019-125232","article-title":"One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity by Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)","volume":"134","author":"Niederwieser","year":"2019","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) C","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: Systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: Systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"iv2","DOI":"10.1093\/jac\/dky050","article-title":"T2 magnetic resonance for the diagnosis of bloodstream infections: Charting a path forward","volume":"73","author":"Clancy","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/mmy\/myv026","article-title":"The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients","volume":"53","author":"Ambasta","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: A systematic review and meta-analysis of cohort studies from the third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: Incidence and risk factors in 395 patients","volume":"116","author":"Martino","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","article-title":"Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study\u2014Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne","volume":"45","author":"Pagano","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.10.2.277","article-title":"Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation","volume":"10","author":"Larocco","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation\u2014A Prospective, Randomized, Double-Blind Study","volume":"171","author":"Slavin","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-Related death in allogeneic marrow transplant recipients: Long-Term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"ref_17","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: Summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: Overview of the transplant- associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of multicenter prospective antifungal therapy (PATH) alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation","volume":"47","author":"Upton","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1469-0691.12002","article-title":"Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil","volume":"19","author":"Nucci","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: A prospective study of the gruppo italiano trapianto midollo osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/tid.12913","article-title":"Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children\u2019s hospital in Argentina","volume":"20","author":"Gomez","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/myc.13029","article-title":"Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation","volume":"63","author":"Linke","year":"2020","journal-title":"Mycoses"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.13205","article-title":"Epidemiology of invasive fungal disease in haematologic patients","volume":"64","author":"Souza","year":"2021","journal-title":"Mycoses"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/00365548.2014.985709","article-title":"Invasive fungal infections in pediatric hematopoietic stem cell transplant patients","volume":"47","author":"Rosen","year":"2015","journal-title":"Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjh.16452","article-title":"Fungal infections in children with haematologic malignancies and stem cell transplant recipients","volume":"189","author":"Otto","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jpids\/piz007","article-title":"Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature","volume":"8","author":"Otto","year":"2019","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41409-018-0161-1","article-title":"Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting","volume":"53","author":"Busca","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/infdis\/jiv143","article-title":"Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis","volume":"212","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/dkx423","article-title":"Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: A post hoc analysis of the SECURE trial","volume":"73","author":"Kontoyiannis","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.11510","article-title":"Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection","volume":"98","author":"Nucci","year":"2003","journal-title":"Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.2020005884","article-title":"How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease","volume":"136","author":"Champlin","year":"2020","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbmt.2015.10.001","article-title":"Acute Graft-versus-Host Disease: Novel Biological Insights","volume":"22","author":"Teshima","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"O939","DOI":"10.1111\/1469-0691.12650","article-title":"Environmental variables associated with an increased risk of invasive aspergillosis","volume":"20","author":"Peghin","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QCO.0b013e32835fb920","article-title":"Pathogenesis of invasive fungal infections","volume":"26","author":"Viasus","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Marr, K.A., Platt, A., Tornheim, J.A., Zhang, S.X., Datta, K., Cardozo, C., and Garcia-Vidal, C. (2020). Aspergillosis Complicating Severe Coronavirus Disease. Emerg. Infect. Dis., 27.","DOI":"10.3201\/eid2701.202896"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Garcia-Vidal, C., Barba, P., Arnan, M., Moreno, A., Ruiz-Camps, I., Gudiol, C., Ayats, J., Ort\u00ed, G., and Carratal, J. (2011). Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin. Infect. Dis., 53.","DOI":"10.1093\/cid\/cir485"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e12981","DOI":"10.1111\/tid.12981","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study","volume":"20","author":"Kuster","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"570.e1","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: A laboratory-based study on resistance mechanisms and genotypes","volume":"22","author":"Jensen","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lamoth, F., Lewis, R.E., and Kontoyiannis, D.P. (2021). Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections. J. Fungi, 7.","DOI":"10.3390\/jof7010017"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11046-014-9775-z","article-title":"Antifungal susceptibility profile of cryptic species of aspergillus","volume":"178","year":"2014","journal-title":"Mycopathologia"},{"key":"ref_48","unstructured":"Escribano, P., Rodr\u00edguez-S\u00e1nchez, B., D\u00edaz-Garc\u00eda, J., Mart\u00edn-G\u00f3mez, M.T., Ib\u00e1\u00f1ez, E., Rodr\u00edguez-Mayo, M., Pel\u00e1ez, T., Garc\u00eda-G\u00f3mez de la Pedrosa, E., Tejero-Garc\u00eda, R., and Marim\u00f3n, J.M. (2020). Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain. Clin. Microbiol. Infect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: A prospective multicenter study involving 2441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/dkz491","article-title":"An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia","volume":"75","author":"Cardozo","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying Amphotericin B-Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T.J., and Kontoyiannis, D.P. (2012). Epidemiology and clinical manifestations of mucormycosis. Clin. Infect. Dis., 54.","DOI":"10.1093\/cid\/cir866"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1086\/509579","article-title":"Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989\u20132006","volume":"43","author":"Lamaris","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/bmt.2015.263","article-title":"Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: A CIBMTR infection and immune reconstitution analysis","volume":"51","author":"Riches","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/clinids\/4.6.1119","article-title":"Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years\u2019 Experience","volume":"4","author":"Meyers","year":"1982","journal-title":"Rev. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful Chemoprophylaxis for Pneumocystis carinii Pneumonitis","volume":"297","author":"Hughes","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10096-006-0149-4","article-title":"Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients","volume":"25","author":"Torres","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: A 6-year retrospective study","volume":"36","author":"Neuville","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/myc.13153","article-title":"Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation","volume":"63","author":"Nematollahi","year":"2020","journal-title":"Mycoses"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jinf.2011.11.002","article-title":"Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer","volume":"64","author":"Chitasombat","year":"2012","journal-title":"J. Infect."},{"key":"ref_64","first-page":"1621","article-title":"Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"O952","DOI":"10.1111\/1469-0691.12688","article-title":"Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: A 4-year study","volume":"20","author":"Lerolle","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: Real-life data from a single-centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijantimicag.2012.02.002","article-title":"Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies","volume":"39","author":"Hoenigl","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e00188-17","DOI":"10.1128\/AAC.00188-17","article-title":"Real-life assessment of the safety and effectiveness of the new tablet and intravenous formulations of posaconazole in the prophylaxis of invasive fungal infections via analysis of 343 courses","volume":"61","author":"Tverdek","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_72","first-page":"237","article-title":"Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study","volume":"55","author":"Kim","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","article-title":"Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole","volume":"40","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1439-0507.2012.02186.x","article-title":"Monitoring trough voriconazole plasma concentrations in haematological patients: Real life multicentre experience","volume":"55","author":"Racil","year":"2012","journal-title":"Mycoses"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"Ratanatharathorn","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jinf.2016.06.011","article-title":"Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients","volume":"73","author":"Park","year":"2016","journal-title":"J. Infect."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.bbmt.2012.03.014","article-title":"Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant","volume":"18","author":"Huang","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jpids\/piaa119","article-title":"A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant","volume":"10","author":"Dvorak","year":"2021","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jinf.2011.12.015","article-title":"Breakthrough invasive mould infections in patients treated with caspofungin","volume":"64","author":"Pang","year":"2012","journal-title":"J. Infect."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S652","DOI":"10.1093\/cid\/civ818","article-title":"Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin","volume":"61","author":"Neofytos","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1592\/phco.27.12.1644","article-title":"Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients","volume":"27","author":"Chou","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/tid.12429","article-title":"Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease","volume":"17","author":"Insunza","year":"2015","journal-title":"Transpl. Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/10\/848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:11:16Z","timestamp":1760166676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/10\/848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,10]]},"references-count":83,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jof7100848"],"URL":"https:\/\/doi.org\/10.3390\/jof7100848","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,10]]}}}